Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand

Shailesh Natvarbhai Mistry, Jeremy Shonberg, Christopher James Draper-Joyce, Carmen Klein Herenbrink, Mayako Michino, Lei Shi, Arthur Christopoulos, Benvenuto Capuano, Peter John Scammells, Jonathan Robert David Lane

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)

Abstract

Recently, we have demonstrated that N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) (1) adopts a bitopic pose at one protomer of a dopamine D2 receptor (D2R) dimer to negatively modulate the binding of dopamine at the other protomer. The 1H-indole-2-carboxamide moiety of 1 extends into a secondary pocket between the extracellular ends of TM2 and TM7 within the D2R protomer. To target this putative allosteric site, we generated and characterized fragments that include and extend from the 1H-indole-2-carboxamide moiety of 1. N-Isopropyl-1H-indole-2-carboxamide (3) displayed allosteric pharmacology and sensitivity to mutations of the same residues at the top of TM2 as was observed for 1. Using 3 as an "allosteric lead", we designed and synthesized an extensive fragment library to generate novel SAR and identify N-butyl-1H-indole-2-carboxamide (11d), which displayed both increased negative cooperativity and affinity for the D2R. These data illustrate that fragmentation of extended compounds can expose fragments with purely allosteric pharmacology.
Original languageEnglish
Pages (from-to)6819-6843
Number of pages25
JournalJournal of Medicinal Chemistry
Volume58
Issue number17
DOIs
Publication statusPublished - 2015

Cite this

Mistry, Shailesh Natvarbhai ; Shonberg, Jeremy ; Draper-Joyce, Christopher James ; Klein Herenbrink, Carmen ; Michino, Mayako ; Shi, Lei ; Christopoulos, Arthur ; Capuano, Benvenuto ; Scammells, Peter John ; Lane, Jonathan Robert David. / Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand. In: Journal of Medicinal Chemistry. 2015 ; Vol. 58, No. 17. pp. 6819-6843.
@article{67b67825db9543879250d24c5dbeee3a,
title = "Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand",
abstract = "Recently, we have demonstrated that N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) (1) adopts a bitopic pose at one protomer of a dopamine D2 receptor (D2R) dimer to negatively modulate the binding of dopamine at the other protomer. The 1H-indole-2-carboxamide moiety of 1 extends into a secondary pocket between the extracellular ends of TM2 and TM7 within the D2R protomer. To target this putative allosteric site, we generated and characterized fragments that include and extend from the 1H-indole-2-carboxamide moiety of 1. N-Isopropyl-1H-indole-2-carboxamide (3) displayed allosteric pharmacology and sensitivity to mutations of the same residues at the top of TM2 as was observed for 1. Using 3 as an {"}allosteric lead{"}, we designed and synthesized an extensive fragment library to generate novel SAR and identify N-butyl-1H-indole-2-carboxamide (11d), which displayed both increased negative cooperativity and affinity for the D2R. These data illustrate that fragmentation of extended compounds can expose fragments with purely allosteric pharmacology.",
author = "Mistry, {Shailesh Natvarbhai} and Jeremy Shonberg and Draper-Joyce, {Christopher James} and {Klein Herenbrink}, Carmen and Mayako Michino and Lei Shi and Arthur Christopoulos and Benvenuto Capuano and Scammells, {Peter John} and Lane, {Jonathan Robert David}",
year = "2015",
doi = "10.1021/acs.jmedchem.5b00585",
language = "English",
volume = "58",
pages = "6819--6843",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "AMER CHEMICAL SOC",
number = "17",

}

Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand. / Mistry, Shailesh Natvarbhai; Shonberg, Jeremy; Draper-Joyce, Christopher James; Klein Herenbrink, Carmen; Michino, Mayako; Shi, Lei; Christopoulos, Arthur; Capuano, Benvenuto; Scammells, Peter John; Lane, Jonathan Robert David.

In: Journal of Medicinal Chemistry, Vol. 58, No. 17, 2015, p. 6819-6843.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand

AU - Mistry, Shailesh Natvarbhai

AU - Shonberg, Jeremy

AU - Draper-Joyce, Christopher James

AU - Klein Herenbrink, Carmen

AU - Michino, Mayako

AU - Shi, Lei

AU - Christopoulos, Arthur

AU - Capuano, Benvenuto

AU - Scammells, Peter John

AU - Lane, Jonathan Robert David

PY - 2015

Y1 - 2015

N2 - Recently, we have demonstrated that N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) (1) adopts a bitopic pose at one protomer of a dopamine D2 receptor (D2R) dimer to negatively modulate the binding of dopamine at the other protomer. The 1H-indole-2-carboxamide moiety of 1 extends into a secondary pocket between the extracellular ends of TM2 and TM7 within the D2R protomer. To target this putative allosteric site, we generated and characterized fragments that include and extend from the 1H-indole-2-carboxamide moiety of 1. N-Isopropyl-1H-indole-2-carboxamide (3) displayed allosteric pharmacology and sensitivity to mutations of the same residues at the top of TM2 as was observed for 1. Using 3 as an "allosteric lead", we designed and synthesized an extensive fragment library to generate novel SAR and identify N-butyl-1H-indole-2-carboxamide (11d), which displayed both increased negative cooperativity and affinity for the D2R. These data illustrate that fragmentation of extended compounds can expose fragments with purely allosteric pharmacology.

AB - Recently, we have demonstrated that N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652) (1) adopts a bitopic pose at one protomer of a dopamine D2 receptor (D2R) dimer to negatively modulate the binding of dopamine at the other protomer. The 1H-indole-2-carboxamide moiety of 1 extends into a secondary pocket between the extracellular ends of TM2 and TM7 within the D2R protomer. To target this putative allosteric site, we generated and characterized fragments that include and extend from the 1H-indole-2-carboxamide moiety of 1. N-Isopropyl-1H-indole-2-carboxamide (3) displayed allosteric pharmacology and sensitivity to mutations of the same residues at the top of TM2 as was observed for 1. Using 3 as an "allosteric lead", we designed and synthesized an extensive fragment library to generate novel SAR and identify N-butyl-1H-indole-2-carboxamide (11d), which displayed both increased negative cooperativity and affinity for the D2R. These data illustrate that fragmentation of extended compounds can expose fragments with purely allosteric pharmacology.

UR - http://pubs.acs.org.ezproxy.lib.monash.edu.au/doi/pdf/10.1021/acs.jmedchem.5b00585

U2 - 10.1021/acs.jmedchem.5b00585

DO - 10.1021/acs.jmedchem.5b00585

M3 - Article

VL - 58

SP - 6819

EP - 6843

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -